Roumell Cuts Exposure to Transcept Pharmaceuticals (TSPT) and Ups Stake in DSP Group (DSPG)

Jim Roumell’s Roumell Asset Management, filed yesterday, two forms disclosing its current positions in Transcept Pharmaceuticals Inc (NASDAQ:TSPT) and DSP Group, Inc. (NASDAQ:DSPG).

In relation to DSP Group, Inc. (NASDAQ:DSPG), Roumell reported an increase in its ownership, to a current amount of 1.06 million shares, from 984,200 shares declared in its last 13F filing. The fund’s holdings in the company are valued at more than $9 million.

DSP Group is a micro-cap (less than $200 million market cap) company that provides system solutions that combine semiconductors and software with reference designs. Despite its razor thin margins and returns, and poor EPS growth projections, its stock trades at 88.5 times the company´s earnings, but only at 1.3 times its sales. However, its valuation does not seem justified. Notwithstanding, Roumell has been upping its stakes in DSP Group, Inc. (NASDAQ:DSPG) for several months now.

Jim Roumell

Other funds betting on DSP Group are D E Shaw, which last reported having increased its stakes by 7% over Q3, to 81,300 shares. On the contrary, the three remaining funds among the top 5 bulls in DSP Group, Inc. (NASDAQ:DSPG), Starboard Value Lp, Nokomis Capital and Renaissance Technologies all reduced their holdings over 2013’s third quarter.

On the other hand, Roumell Asset Management declared trimming its position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT), currently holding 2.20 million shares, Roumell reduced its participation in the company by about 2%, in relation to its last 13F filing, for 2013′s Q3. The stake held by Roumell now amasses around 11.7% of the outstanding stock. Earlier, the fund acknowledged selling 48,200 shares of the company. Then, on Dec. 31st, it sold another 59,600 shares.

These moves are quite understandable, given Transcept Pharmaceuticals Inc (NASDAQ:TSPT)’s negative margins and returns and awful growth projections. In fact, most analysts seem to agree on the idea that Transcept is clearly a “hold” case, for now. However, other hedge fund managers like Jim Simons, D. E. Shaw, Cliff Asness and Paul Touradji do not seem to agree with this view, as all of them last reported having added this company´s stock to their equity portfolios (and we are talking about, at least, 10,000 shares each).

Disclosure: Javier Hasse holds no position in any stocks mentioned

Recommended Reading:

Baupost Group Buys Over 16 Mln Shares of Idenix Pharmaceuticals Inc (IDIX)

Ra Capital Management Initiates Stake in Furiex Pharmaceuticals Inc (FURX) After the Stock Jumped

Deerfield Management Discloses Stake in Post-IPO Auspex Pharmaceuticals Inc (ASPX)

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Top 10 Most Expensive Luxury Cars in the World – 2014

Killer Small Business Ideas

The 50 Best Personal Finance Blogs

Most Expensive Apartments in New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!